FDA 483 - Hetero Labs Limited (Unit III) - August 28, 2014
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Hetero Labs Ltd. Unit III in Nallapally Mandal, India, an intermediate manufacturer, revealed two significant observations. The firm failed to establish appropriate controls on computerized systems in the Quality Control Laboratory, specifically lacking audit trails for analytical equipment. Additionally, the accuracy, sensitivity, specificity, and reproducibility of HPLC test methods for intermediates were not established, with method transfer not performed for several intermediates.
ID · d0329c01-18bd-45d1-91c5-17ed4be5cc84